The Fellow on Call: The Heme/Onc Podcast Episode 121: AML Series, Pt 7 - AML Consolidation: Role of Allogeneic Transplant
Nov 6, 2024
Delve into the complexities of consolidation therapies for acute myeloid leukemia (AML). Discover the pivotal role of allogeneic stem cell transplants in improving patient outcomes. Learn about high-dose vs. lower-dose cytarabine treatments and their effects on relapse prevention. Explore the evolution of transplant techniques, including donor matching and conditioning methods. Plus, see how minimal residual disease (MRD) testing shapes treatment strategies, potentially minimizing unnecessary transplants while boosting survival rates.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 4min
High-Dose Consolidation Therapy and Allogeneic Transplantation in AML
04:28 • 4min
Advancements in Allogeneic Stem Cell Transplantation for AML
08:18 • 5min
The Evolution of Transplant Strategies in Acute Myeloid Leukemia
12:50 • 6min
Integrating MRD Testing in AML Management
18:29 • 6min